DeepBiome Therapeutics logo

DeepBiome Therapeutics

Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome.

est. 2017

VS
Nexo Therapeutics logo

Nexo Therapeutics

We’re driven to translate the most compelling and still undrugged targets in human biology into medicines for patients

19 employees · est. 2022 · Watertown, United States

DeepBiome Therapeutics is the older company (2017 vs 2022).

Side-by-Side Comparison

DeepBiome Therapeutics Nexo Therapeutics
Founded
2017 older 2022
Headquarters
Not tracked yet Watertown, United States
Employees
Not tracked yet 19
Industry
Biopharma, Biotechnology, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Series Unknown Series A
Total Funding
$2.51M $60.00M
Funding Rounds
2 1
Services
Not tracked yet Chemical Biology R&D, Covalent Drug Design, Biomedical Research, Biotech Innovations
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Researchers, Healthcare Institutions, Drug Development Firms
Taxonomy
Drug Discovery, Deep Learning, Synthetic Biology, Microbiome, Therapeutic Potential, Pharmaceutical Companies, Technology, Startup, Biotech, Allston, Massachusetts, Innovation Oncology, Cancer Therapy, Small Molecule Drugs, Covalent Ligand Discovery, Chemical Biology, Cancer Biology, Medicinal Chemistry, Drug Discovery, Biopharmaceutical, Precision Medicine, Innovation, Scientific Expertise, Clinical Trials
Website
deepbiometherapeutics.com nexotx.com
DeepBiome Therapeutics logo

About DeepBiome Therapeutics

DeepBiome Therapeutics is a biotechnology firm founded in 2017 and headquartered in Allston, Massachusetts. The company's slogan, "Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome," encapsulates its focus on developing an innovative drug discovery...

Nexo Therapeutics logo

About Nexo Therapeutics

Nexo Therapeutics, founded in 2022, is a dynamic player in the Biotechnology and Life Sciences industries, based in the United States. The company is committed to creating innovative small molecule therapies targeting cancer, particularly for patients lacking substantial treatment options. This alig...

We will tell you when either one moves

BounceWatch watches DeepBiome Therapeutics and Nexo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DeepBiome Therapeutics and Nexo Therapeutics — by email.

Frequently Asked Questions

DeepBiome Therapeutics — Harnessing deep learning and synthetic biology to harness the therapeutic potential of the microbiome.. Nexo Therapeutics — We’re driven to translate the most compelling and still undrugged targets in human biology into medicines for patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DeepBiome Therapeutics has raised $2.51M while Nexo Therapeutics has raised $60.00M.
DeepBiome Therapeutics and Nexo Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DeepBiome Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at DeepBiome Therapeutics on 26 Jul 2024, and Nexo Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes